Sangani Hospitals Ltd
Incorporated in 2021, Sangani Hospitals is in the business of Hospital, Laboratory, and Pharmacy[1]
- Market Cap ₹ 62.0 Cr.
- Current Price ₹ 45.0
- High / Low ₹ 77.0 / 37.0
- Stock P/E 25.8
- Book Value ₹ 27.9
- Dividend Yield 0.00 %
- ROCE 8.87 %
- ROE 6.44 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Promoter holding has increased by 0.87% over last quarter.
- Company's working capital requirements have reduced from 37.0 days to 24.4 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 7.86% over last 3 years.
- Debtor days have increased from 62.6 to 82.8 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 4.20 | 11.66 | 12.24 | 16.80 | 21.11 | |
| 2.75 | 8.57 | 9.14 | 14.31 | 17.67 | |
| Operating Profit | 1.45 | 3.09 | 3.10 | 2.49 | 3.44 |
| OPM % | 34.52% | 26.50% | 25.33% | 14.82% | 16.30% |
| 0.00 | 0.03 | 0.82 | 1.57 | 0.64 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.06 | 1.07 | 0.28 | 0.59 | 0.75 |
| Profit before tax | 1.39 | 2.05 | 3.64 | 3.47 | 3.33 |
| Tax % | 25.18% | 24.88% | 25.55% | 25.07% | 27.93% |
| 1.04 | 1.53 | 2.70 | 2.59 | 2.40 | |
| EPS in Rs | 2.63 | 1.53 | 1.96 | 1.88 | 1.74 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 22% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 8% |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 3.95 | 9.99 | 13.78 | 13.78 | 13.78 |
| Reserves | 1.04 | 8.01 | 19.71 | 22.31 | 24.71 |
| 0.03 | 0.00 | 0.00 | 0.00 | 0.50 | |
| 1.62 | 1.22 | 1.49 | 2.58 | 5.56 | |
| Total Liabilities | 6.64 | 19.22 | 34.98 | 38.67 | 44.55 |
| 0.86 | 11.87 | 12.67 | 13.16 | 16.50 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 |
| Investments | 0.00 | 0.81 | 0.84 | 0.82 | 19.94 |
| 5.78 | 6.54 | 21.47 | 24.69 | 7.91 | |
| Total Assets | 6.64 | 19.22 | 34.98 | 38.67 | 44.55 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 2.25 | 3.31 | 2.39 | 6.46 | ||
| -12.84 | -1.11 | -1.07 | -23.41 | ||
| 11.45 | 12.42 | -2.26 | 0.49 | ||
| Net Cash Flow | 0.86 | 14.62 | -0.94 | -16.46 | |
| Free Cash Flow | -9.77 | 2.23 | 1.30 | 2.17 | |
| CFO/OP | 88% | 129% | 124% | 208% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 203.36 | 60.73 | 53.38 | 51.71 | 82.82 |
| Inventory Days | 160.09 | 48.98 | 92.54 | 114.53 | 49.93 |
| Days Payable | 448.25 | 85.32 | 128.52 | 83.07 | 114.14 |
| Cash Conversion Cycle | -84.80 | 24.39 | 17.39 | 83.17 | 18.62 |
| Working Capital Days | 88.64 | 42.26 | 37.57 | 48.88 | 24.38 |
| ROCE % | 18.33% | 14.14% | 9.97% | 8.87% |
Insights
In beta| Mar 2023 | Mar 2024 | |
|---|---|---|
| Annual Dialysis Sessions Sessions |
|
|
| Consulting Doctors (Keshod) Count |
||
| Consulting Doctors (Veraval) Count |
||
| Dialysis Patients Treated Patients |
||
| Permanent Doctors (Keshod) Count |
||
| Permanent Doctors (Veraval) Count |
||
| Sangani Hospital (Keshod) Bed Capacity Beds |
||
| Sangani Super Speciality Hospital (Veraval) Bed Capacity Beds |
||
| Total Bed Capacity Beds |
||
| Total Medical and Support Staff Count |
||
Extracted by Screener AI
Documents
Announcements
-
Outcome of Board Meeting
30 May 2026 - Board approved FY26 audited standalone and consolidated results; appointed SMNK & Company as internal auditor for FY27.
-
Structural Digital Database
25 May 2026 - SDD compliance certificate for FY ended March 31, 2026; no non-compliance observed.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
30 April 2026 - Sangani Hospitals Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Updates
30 April 2026 - Sangani Hospitals Limited has informed regarding 'Non-applicability of Regulation 24A of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015 regarding Annual Secretarial Compliance Report'.
-
Updates
30 April 2026 - Sangani Hospitals Limited has informed regarding 'Large Corporate Non-Applicability'.
Business Overview:[1][2]
SHL is in the business of Hospitals, pathological laboratory and Pharmacy stores. It operates 2 hospitals viz. Sangani Hospital at Keshod, Gujarat, and Sangani Super Speciality Hospital, Veraval, Gujarat. It also operates 2 pathology laboratories and 2 medical stores.